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ScienceDirectEscherichia coli cyclic-AMP receptor protein (CRP) represents
one of the paradigms of bacterial gene regulation. Yet despite
decades of intensive study, new information continues to
emerge that prompts reassessment of this classic regulatory
system. Moreover, in recent years CRPs from several other
bacterial species have been characterized, allowing the general
applicability of the CRP paradigm to be tested. Here the
properties of the E. coli, Mycobacterium tuberculosis and
Pseudomonas putida CRPs are considered in the context of the
ecological niches occupied by these bacteria. It appears that
the cyclic-AMP-CRP regulatory system has been adapted to
respond to distinct external and internal inputs across a broad
sensitivity range that is, at least in part, determined by bacterial
lifestyles.
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The Escherichia coli paradigm
The cyclic-AMP receptor protein (CRP) and its effector
cyclic-AMP (cAMP) were discovered in E. coli during
investigations to explain the phenomenon of diauxic
growth more than 40 years ago. Since then, E. coli
CRP–cAMP has become a paradigm of gene regulation,
providing insights into signal perception and transduc-
tion, DNA recognition by regulatory proteins, regulator–
polymerase interactions and promoter architecture [1].
Open access under CC BY license. www.sciencedirect.com The formation of the second messenger cAMP from ATP
is catalyzed by a group of enzymes known as adenylyl
cyclases. These enzymes are classified into six groups
based on their primary structures. E. coli possesses a single
Class I adenylyl cyclase (Cya) whose activity is controlled
by glucose availability, such that growth at micromolar
concentrations of glucose increases intracellular cAMP
concentrations 10-fold (20 mM to 180 mM) compared
to excess glucose conditions [2]. The consensus view has
been that when the preferred carbon source glucose is
available, it is transported into the cell by the glucose
phosphotransferase system (PTS) and glucose enters the
cytoplasm as glucose-6-phosphate [3,4]. The phosphoryl-
ation state of the PTS thus acts as a reporter of glucose
availability — the phosphorylation state of the PTS is
lower when the glucose transporter is saturated, whereas
when glucose is absent, phosphorylated PTS proteins
accumulate. The phosphorylated PTS interacts with
Cya to enhance adenylyl cyclase activity [3]. Thus, when
the bacteria are glucose-starved, the intracellular cAMP
concentration increases as a consequence of the altered
phosphorylation state of the PTS; however this is difficult
to reconcile with observations that the glucose PTS is still
saturated when intracellular cAMP concentrations
increase [2]. Consequently, it has been suggested that
cAMP concentrations increase in response to low energy
charge, such that when ATP is low, cAMP is high,
promoting catabolism and inhibiting anabolism by
CRP–cAMP-mediated gene regulation to bridge the per-
ceived energy deficit [5].
Degradation of cAMP is mediated by a phosphodiester-
ase, CpdA, but this enzyme has a rather high Km for cAMP
(500 mM) relative to the concentration of cAMP in the
cell, and a cpdA mutant exhibited only a twofold increase
in intracellular cAMP concentration [6]. Consequently,
the observation that cAMP is often found extracellularly
(0.03–0.5 mM) led to the finding that E. coli can quench
intracellular levels of cAMP by TolC-mediated efflux,
although the cAMP transporter(s) that links to the outer-
membrane pore TolC has not yet been identified [7].
Changes in intracellular cAMP concentration are per-
ceived by the transcription factor CRP. CRP is a homo-
dimer in which each subunit possesses three major
structural features (Figure 1). The N-terminal region
houses the high-affinity cAMP-binding domain and the
C-terminal region consists of a DNA-binding domain
with a canonical helix-turn-helix motif. These twoCurrent Opinion in Microbiology 2014, 18:1–7
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Relevant structural features of the E. coli CRP–cAMP–DNA complex. The CRP dimer (one protomer in brown, the second in blue) is shown in cartoon
representation with the DNA-recognition helices highlighted in green. The locations of the C-helices at the dimer interface, the D-helices of the DNA-
binding domain and the key residues Ser-128 and Asp-138 are indicated. Cyclic-AMP molecules bound in the anti-conformation at the higher affinity
sites in the sensory domain and in the syn-conformation at the low affinity sites close to the DNA are shown in a ‘space-fill’ representation. DNA is
shown as a pale gray ribbon. The diagram was constructed using Pymol [34].domains are connected by a long helix (C-helix) that
forms a coiled-coil at the dimer interface and a short
linker followed by another helix (D-helix) (Figure 1).
Cyclic-AMP binding to the sensory domain is
initially exothermic (DH1 = 16.3 kJ mol1; DS1 =
41 J K1 mol1) followed by an endothermic phase
(DH2 = 25.1 kJ mol
1; DS2 = 176 J K
1 mol1) and cAMP
interactions with the two protomers that make up the CRP
dimer are cooperative (DG2  DG1 = 2.7 kJ mol1) with
binding constants of 8  104 M1 for site 1 and 6 
104 M1 for site 2 [8].
In the apo-CRP dimer, the two DNA-binding domains
interact to form a rigid body in which the DNA-recog-
nition helices are buried such that they cannot interact
with DNA [9]. Binding of cAMP to CRP initiates struc-
tural rearrangements about a ‘hinge’ region allowing the
DNA-binding domains to relocate relative to the cAMP-
binding domain in a process mediated through hydrogen
bonds between the N(6) position of adenosine with Ser-
128 of the dimerization helices (C-helices; Figure 1)
[9,10]. This allosteric conversion critically involves exten-
sion of the C-helices by six residues and shortening of the
D-helices by four residues, such that Asp138 becomes the
N-terminal capping residue of the D-helix in CRP–cAMP
(Figure 1), but is an internal part of the longer D-helix in
apo-CRP (Figure 2a and b). The helix-capping propen-
sity of residue 138 is correlated to the degree of co-
operative cAMP-binding and hence this property ofCurrent Opinion in Microbiology 2014, 18:1–7 Asp138 is a key feature of the interdomain conformational
changes that modulate the apo-CRP $ CRP–cAMP
equilibrium [8]. NMR spectroscopy and thermodynamic
analyses of several CRP variants revealed how changes in
conformational entropy modulate DNA-binding activity
[11]. These structural rearrangements expose the DNA-
recognition helices (highlighted in green in Figure 1)
such that they are able to participate in sequence specific
(consensus sequence TGTGAnnnnnnTCACA) binding
at two adjacent major grooves of DNA (Figure 2b) [12].
Cyclic-AMP binding has a biphasic effect on site-specific
DNA-binding by CRP. High-affinity binding of cAMP in
the anti-conformation at the sensory domains of the CRP
subunits (1:1 cAMP/CRP protomer) enhances DNA-
binding 1000-fold. This is followed by decreased
DNA-binding when cAMP in the syn-conformation inter-
acts with weak binding sites formed by components of the
helix-turn-helix, a b-hairpin from the regulatory domain
and DNA (2:1 cAMP/CRP protomer) [13]. However,
proof that cAMP-binding to these low affinity sites is
of physiological significance has not yet been provided.
CRP–cAMP binding to intergenic CRP sites is associated
with classical gene regulation [14,15]; however, it is now
recognized that CRP–cAMP also binds at many intra-
genic sites where it is thought to fulfill a role as a
chromosome organizer or nucleoid associated protein
(NAP) [14]. Genome SELEX screening identified at leastwww.sciencedirect.com
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X-ray crystal structures of Escherichia coli and Mycobacterium tuberculosis CRPs in the absence and presence of cAMP. (a) E. coli apo-CRP (PDB ID
3HIF). (b) E. coli cAMP–CRP (PDB ID 2CGP). (c) M. tuberculosis apo-Rv3676 (PDB ID 3D0S). (d) M. tuberculosis cAMP-Rv3676 (PDB ID 3MZH). The
diagram was constructed and the features are highlighted as described in the legend to Figure 1.254 CRP-binding sites across the E. coli genome and
because CRP is capable of controlling expression of diver-
gent promoters from a single binding site it is estimated
that CRP–cAMP directly controls a minimum of 378
promoters, and perhaps >500 genes in E. coli [15].
Amongst these operons, CRP–cAMP acts as the ‘master’
regulator for 70 ‘slave’ transcription factors further expand-
ing the profound influence of CRP on global gene expres-
sion in E. coli, in which it plays a key role in managing
catabolism, including the transport of substrates, glycoly-
sis, the Krebs cycle and aerobic respiration [15,16].
Variation 1 — Mycobacterium tuberculosis
CRP, Rv3676, a regulator evolved to operate
at high cAMP concentrations?
Unlike E. coli, which has only one adenylyl cyclase, M.
tuberculosis H37Rv possesses at least 16 Class III adenylyl
cyclase-like proteins, including soluble and membrane-
associated multidomain proteins, suggesting that their
catalytic activities (10 of the 16 have been shown to act
as adenylyl cyclases) can be regulated by extracellularwww.sciencedirect.com and/or intracellular signals, reviewed by Chakraborti [17].
Accordingly, adenylyl cyclase activity of M. tuberculosis is
affected by pH, CO2, and fatty acids. It has long been
recognized that mycobacteria secrete cAMP, but it is only
more recently that the capacity to intoxicate macrophages
with cAMP has been recognized as a contributor to
virulence [18,19]. Thus, the synthesis (in particular by
Rv0386) and secretion of cAMP are central features of M.
tuberculosis pathogenesis and result in the bacterium being
exposed to relatively high concentrations of cAMP; there
are reports of intracellular concentration of cAMP as high
as 4 mM for M. tuberculosis H37Rv and 3 mM for Myco-
bacterium smegmatis, which far exceed values reported for
E. coli [20,21]. However, it is wise to offer a note of
caution here; because the different growth conditions and
methods used to measure cAMP, it is difficult to make
direct comparisons. Nevertheless, the important role
that cAMP plays in tuberculosis pathogenesis exposes
the need for careful investigation of both intracellular
and extracellular cAMP concentrations using modern
approaches.Current Opinion in Microbiology 2014, 18:1–7
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Table 1
Comparison of features of cAMP-signaling in three bacteria
Bacterium M. tuberculosis E. coli P. putida
Niche Lung macrophage Mammalian intestine Soil
Number of adenylyl cyclases 16 1 2
Intracellular cAMP concentrations High Moderate Low
CRP Rv3676 CRP PP_0424
cAMP–CRP interactions Independent binding Cooperative binding Independent binding
KD for cAMP 60 mM 13–16 mM 23 nM
Motif for cAMP interactiona E. . .TS. . .R. . .TN E. . .RS. . .R. . .TS E. . .RS. . .R. . .TT
Number of phosphodiesterases 1 1 1
Number of chromosomal binding sitesb >70 >378 >30
a Amino acids involved in direct interaction with cAMP in E. coli CRP as single letter code with dots (. . .) representing intervening regions of various
lengths. The amino acid at the position equivalent to Ser-128 in E. coli CRP that makes a cross-subunit contact with cAMP is shown in bold font.
b The binding site numbers represent: matches to the Rv3676 consensus sequence identified by Rickman et al. [28] in the M. tuberculosis H37Rv
genome sequence; E. coli CRP-binding sites suggested by Shimada et al. [15] following genomic SELEX analysis; and a minimum value based on
interrogation of the P. putida KT2440 genome sequence by the E. coli CRP-binding site consensus [30].The relatively high concentrations of cAMP reported for
mycobacteria are consistent with the presence of multiple
adenylyl cyclases but of only one cAMP phosphodiester-
ase (Rv0805) in M. tuberculosis H37Rv. Moreover, the
cAMP phosphodiesterase activity of Rv0805 is poor,
and like its E. coli counterpart, it has a relatively high
Km for cAMP (150 mM) [22]. This rather poor in vitro
activity is reflected in vivo, where overproduction of
Rv0805 resulted in only a 30% decrease in cAMP (a
90% decrease was observed for overproduction of CpdA
in E. coli), perhaps indicating alternative roles for this
enzyme, which also possesses the ability to hydrolyze a
range of cNMP and linear phosphodiesters [23]. In the
light of these data, it has been suggested that intracellular
cAMP levels might be controlled by excretion rather than
conversion to AMP but, as is the case for E. coli, there is a
need to establish the mechanism(s) of cAMP secretion
and how this might be regulated.
The M. tuberculosis CRP (Rv3676; 32% amino acid identity
to E. coli CRP over 189 amino acids, including four of the
six key cAMP-interacting residues in the sensory domain of
E. coli CRP; Table 1) differs from the E. coli paradigm at
several levels. The Rv3676 homodimer exhibits relatively
weak (Kb = 1.7  104 M1) binding of cAMP to two inde-
pendent sites (1:1 cAMP/protomer). Furthermore, cAMP-
binding is endothermic (DH = 30.7 kJ mol1; DS =
183 J K1 mol1; DG = 23.7 kJ mol1) and thus binding
is entropically driven [24]. The independent nature of
cAMP-binding to Rv3676 compared to E. coli CRP was
accounted for by the replacement of a single amino acid
residue (Ser-128 of CRP, which is required for the dramatic
conformational changes that occur upon cAMP-binding, is
replaced by Asn in Rv3676) that has the effect of reorga-
nizing a hydrogen-bonding network involving cAMP such
that the cAMP-binding sites in Rv3676 are uncoupled [24].
It has been argued that the relatively weak and indepen-
dent binding of cAMP at the sensory domain of Rv3676
has evolved to allow the protein to be at least partiallyCurrent Opinion in Microbiology 2014, 18:1–7 cAMP-responsive against the background of high cAMP
concentrations required to intoxicate the host during
infection.
The crystal structures of apo-Rv3676 and Rv3676-cAMP
reveal that cAMP-binding is associated with much less
dramatic structural rearrangements than those observed
for E. coli CRP [25–27] (Figure 2c and d). The major
alteration that occurs upon cAMP-binding is weakening
of the interactions between the DNA-binding and sen-
sory domains, resulting in increased spatial freedom of the
DNA-binding domain that is apparently sufficient to
permit binding to target DNA sequences by an induced
fit mechanism [27].
Consistent with the relatively mild structural rearrange-
ments that occur upon cAMP-binding by Rv3676, the
formation of the Rv3676–cAMP complex has a relatively
small effect (2-fold) on DNA-binding to a consensus
sequence that is very similar to that of E. coli
(GTGnnAnnnnnCACA) [28]. Furthermore, unlike E. coli
CRP, apo-Rv3676 is capable of site-specific DNA-binding
and transcription regulation [24]. These observations are
consistent with the limited overlap between genes dysre-
gulated in the crp mutant and those affected by Rv0805
overproduction [23] and suggests that the primary role of
Rv0805 might not be to act as a cAMP phosphodiesterase
and/or that Rv3676 can significantly influence gene expres-
sion without the need to bind cAMP.
Like E. coli CRP, M. tuberculosis Rv3676 is a global
regulator but, perhaps unsurprisingly in the context of
the very different lifestyles of these two bacteria, the
corresponding CRP regulons differ. Thus Rv3676 appears
to be involved in regulating the transition between repli-
cating and nonreplicating states by exerting influence
over virulence-critical functions, including phthiocerol
dimycocerosate (DIM) synthesis, resuscitation promoting
factors, the ESX-1 type VII secretion system, carbonwww.sciencedirect.com
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factors, such as the nitric oxide-responsive regulator
WhiB1 [28,29]. This degree of control over the transcrip-
tome is consistent with the attenuated state of the M.
tuberculosis crp mutant in models of infection [28].
Variation 2 — Pseudomonas putida CRP,
PP_0424, a regulator evolved to operate at low
cAMP concentrations?
P. putida possesses a CyaA-type adenylyl cyclase capable
of cAMP synthesis (and there is also a second protein
PP_5187 annotated as an adenylyl cyclase), but never-
theless cAMP concentrations are below the level of detec-
tion in bioassays [30]. P. putida KT2440 possesses a cAMP
phosphodiesterase (PP_4917) equivalent to the E. coli
CpdA protein. Thus, the very low levels of cAMP in P.
putida could arise from poor synthesis or rapid degradation,
but based on complementation experiments with E. coli cya
mutants the former is the more likely. Thus, P. putida
seems to represent the opposite end of the ‘cAMP spec-
trum’ to M. tuberculosis. The P. putida CRP is 63% amino
acid identical to E. coli CRP over 208 amino acids, in-
cluding five out of the six cAMP-interacting residues in the
sensory domain of E. coli CRP — interestingly the mis-
match is again located at the position equivalent to 128 in
E. coli CRP (Table 1). Consistent with the very low
concentrations of cAMP, the P. putida CRP exhibits very
high affinity (Kb = 4.4  107 M1) binding of cAMP to two
independent sites (1:1 cAMP/protomer). Furthermore,
cAMP-binding is exothermic (DH = 25 kJ mol1; DS =
63 J K1 mol1; DG = 10.5 kJ mol1), and binding is both
enthalpy and entropy driven [31]. Although detailed
structural information is not yet available, this hypersensi-
tive binding of cAMP invokes large conformational
changes that can be detected by size exclusion chroma-
tography and result in enhanced DNA-binding to a typical
CRP inverted repeat sequence by >10-fold [31].
Although P. putida exhibits catabolite repression, this
behavior is not mediated by CRP–cAMP, as a crp mutant
was unaffected in its ability to utilize a full range of sugars
as carbon sources [32]. Rather, CRP–cAMP appears to
control the utilization of L-phenylalanine and of various
dipeptides as nitrogen sources in P. putida [30,33]. The
full range of genes regulated by CRP in P. putida has not
been established but a conservative analysis of the gen-
ome sequence for likely binding sites indicates that >30
genes might be regulatory targets, few of which appear to
have a metabolic role [30]. These observations led to the
suggestion that P. putida and M. tuberculosis CRPs have
evolved to control different biological processes com-
pared to the E. coli paradigm, a possible example of
regulatory exaptation [30].
Perspectives and outstanding questions
In recent years many aspects of the cAMP-signaling CRP-
regulatory paradigm that has emerged from intensivewww.sciencedirect.com studies of catabolite repression in E. coli have come under
closer scrutiny. Almost every step from the relationship
between the activity of the glucose PTS and cAMP
synthesis to the role of cAMP–CRP in gene regulation
and chromosome organization has been reassessed. The
picture that is emerging is one in which intracellular and
extracellular cAMP concentrations are modulated by
adenylyl cyclases, phosphodiesterases and cAMP efflux
systems some of which respond to external and/or internal
signals. Changes in intracellular cAMP concentration are
perceived by CRP proteins that react with different
sensitivities related to the niches occupied by the bac-
teria. Thus, the pathogen M. tuberculosis Rv3676 is a low
sensitivity CRP evolved to maintain some degree of
responsiveness at the high cAMP concentrations used
to intoxicate host macrophages; the commensal enteric
bacterium E. coli possesses a mid-sensitivity CRP to
regulate catabolite repression and chromosome structure,
probably in response to energy charge; and the soil
bacterium P. putida has a hypersensitive CRP, reflecting
the very low concentrations of cAMP produced by this
bacterium. Nevertheless, despite decades of study there
are still many outstanding questions that need to be
addressed to complete our understanding of cAMP-sig-
naling in E. coli and other bacteria. For example, at the
root of cAMP-mediated signaling in bacteria is the ability
to synthesize and degrade cAMP in response to environ-
mental and metabolic signals. To place investigations of
cAMP-signaling on a sound footing there is a need to
apply the latest metabolite quenching, extraction and
analysis techniques to accurately measure intracellular
and extracellular cAMP concentrations under diverse
growth conditions.
Further characterization of the phosphodiesterases
involved in cAMP degradation and the processes required
for cAMP excretion is required. Signal-dependent syn-
thesis of cAMP is only one component in controlling
bacterial responses to this second messenger; there have
to be mechanisms for removing cAMP from the system. It
appears that the cAMP phosphodiesterases are rather
poor enzymes, leading to the suggestion that secretion
of cAMP might be the major route to lowering cAMP in
the cell. However, thus far no cAMP efflux systems have
been identified beyond the recognition that TolC is
involved in facilitating cAMP crossing the outer mem-
brane of E. coli. Identifying cAMP secretion systems and
defining their role in bacterial signaling and pathogenesis
will fill a major deficit in our current knowledge.
It will be informative to seek physiological and evolution-
ary explanations for the differences in cAMP-binding to
the regulatory CRP proteins in different bacteria, in
particular, establishing whether CRPs, like that of M.
tuberculosis, which exhibits only a mild enhancement in
DNA-binding in response to cAMP, control cAMP-
independent and cAMP-dependent regulons. Similarly,Current Opinion in Microbiology 2014, 18:1–7
6 Cell regulationmechanistic explanations for the extremely avid cAMP-
binding by CRPs, as exemplified by the P. putida CRP,
should be sought. At present it appears that responding to
the second messenger cAMP allows CRP to be co-opted
to control different regulons in bacteria that occupy
distinct niches. Thus, because cAMP intoxication of
the host is an important component of M. tuberculosis
pathogenicity, its CRP has become desensitized to
cAMP, whereas the CRP of the soil bacterium P. putida
has become hypersensitive to cAMP. Hence through a
common mechanism of CRP-mediated RNA polymerase
recruitment and signal-dependent cAMP synthesis/
degradation (e.g. glucose availability in E. coli; pH and
other virulence-related signals in M. tuberculosis; unknown
signals possibly related to the utilization of aromatic
amino acids and nitrogen sources by P. putida), CRP
has been co-opted to control distinct regulons according
to the particular niches occupied by the bacteria. Devel-
oping a mechanistic framework that accounts for the
shifts in cAMP-binding affinities observed in different
CRPs would then allow questions about the physiological
roles of cAMP–CRP complexes with alternative stoichi-
ometries to be addressed.
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